“In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation Mitochondrial Function through SIRT1 Activation”.
Vilella R.; Izzo S.; Naponelli V.; Savi M.; Bocchi L.; Dallabona C.; Gerra MC.; Stilli D.; Bettuzzi S.
2022, Pharmaceuticals 15, no 11: 1337

“Efficacy of a Polyphenolic, Standardized Green Tea Extract for the Treatment of COVID-19 Syndrome: A Proof-of-Principle Study”. 
Bettuzzi S.; Gabba L.; Cataldo S. 
2021, COVID 1, no. 1: 2-12. 

“Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention”. 
Izzo S.; Naponelli V.; Bettuzzi S. 
2020, Nutrients 12, no. 4: 1010. 

“Effects of Standardized Green Tea Extract and Its Main Component, EGCG, on Mitochondrial Function and Contractile Performance of Healthy Rat Cardiomyocytes”.
Vilella R.; Sgarbi G.; Naponelli V.; Savi M.; Bocchi L.; Liuzzi F.; Righetti R.; Quaini F.; Frati C.; Bettuzzi S.; Solaini G.; Stilli D.; Rizzi F.; Baracca A. 
2020, Nutrients, Sep 25;12(10):E2949. doi: 10.3390/nu12102949. PMID: 32993022. 

“Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer”. 
Negri A.; Naponelli V.; Rizzi F.; Bettuzzi S. 
2018, Nutrients, Dec 6;10(12):1936. doi: 10.3390/nu10121936. PMID: 30563268; PMCID: PMC6315581. 

“Long-Term Oral Administration of Theaphenon-E Improves Cardiomyocyte Mechanics and Calcium Dynamics by Affecting Phospholamban Phosphorylation and ATP Production”. 
Bocchi L.; Savi M.; Naponelli V.; Vilella R.; Sgarbi G.; Baracca A.; Solaini G.; Bettuzzi S.; Rizzi F.; Stilli D.
2018, Cell Physiol Biochem. 47(3):1230-1243. doi: 10.1159/000490219. Epub 2018 Jun 15. PMID: 29913456. 

“Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges”. 
Naponelli V.; Ramazzina I.; Lenzi C.; Bettuzzi S.; Rizzi F. 
2017, Antioxidants 6, no. 2: 26.

“Chapter 95 – Human Prostate Cancer Prevention by Green Tea Catechins: Clinical Trial and Putative Molecular Mechanisms of Action. Tea in health and disease prevention”. 
Rizzi F.; Bettuzzi S. 
2013, pages 1129-1144.

“A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis”.
Dryden G. W.; Lam A.; Beatty K.; Qazzaz H. H.; McClain C. J. 
2013, Inflammatory Bowel Diseases, Volume 19, Issue 9, 1 August 2013, Pages 1904–1912. 

“Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update”. 
Brausi M.; Rizzi F.; Bettuzzi S. 
2008, Eur Urol. Aug;54(2):472-3. doi: 10.1016/j.eururo.2008.03.100. Epub 2008 Apr 4. PMID: 18406041. 

“Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer”. 
McCarthy S.; Caporali A.; Enkemann S.; Scaltriti M.; Eschrich S.; Davalli P.; Corti A.; Lee A.; Sung J.; Yeatman TJ.; Bettuzzi S. 
2007, Mol Oncol. Sep;1(2):196-204. doi: 10.1016/j.molonc.2007.05.007. PMID: 18521193; PMCID: PMC2408886. 

“Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study”. 
Bettuzzi S.; Brausi M.; Rizzi F.; Castagnetti G.; Peracchia G.; Corti A. 
2006, Cancer Res. Jan 15;66(2):1234-40. doi: 10.1158/0008-5472.CAN-05-1145. PMID: 16424063.